Skip to main content
Market intelligence
ABCLHealthcare

AbCellera Biologics Inc insider activity

In the last 90 days, 3 corporate insiders purchased $975,237 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$975,237
Corporate buyers
3
Latest transaction
Aug 18, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 18, 2026John S. MontalbanoCorporate insiderOpen Market Purchase10,000$11.03$110,300
Aug 14, 2026Andrew BoothChief Financial OfficerOpen Market Purchase37,200$10.32$383,904
Aug 12, 2026Michael R HaydenCorporate insiderOpen Market Purchase46,387$10.37$481,033